Taghiloo et al. [17] discovered that galectin-9 levels were 30 times higher in the malignant cells of CLL patients which resulted in T cell exhaustion and an imbalance of CD4 + T cell subsets in CLL. This evidence concerns the gene LGALS9 and B-cell chronic lymphocytic leukemia.